We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.38B
AUM Growth
+$228M
Cap. Flow
+$112M
Cap. Flow %
4.7%
Top 10 Hldgs %
27.75%
Holding
541
New
208
Increased
87
Reduced
79
Closed
146

Top Buys

Rank Stock Value
1
LOGI icon
Logitech
LOGI
+$77.6M
2
QGEN icon
Qiagen
QGEN
+$47.1M
3
BAC icon
Bank of America
BAC
+$43.7M
4
WUBA
58.com Inc
WUBA
+$42.5M
5
META icon
Meta Platforms (Facebook)
META
+$28.9M

Sector Composition

Rank Sector Weight
1 Healthcare 18.17%
2 Communication Services 17.26%
3 Technology 13.02%
4 Financials 9.58%
5 Consumer Discretionary 8.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
326
Visa
V
$677B
$386K 0.02%
3,385
-25,846
-88% -$2.85M
LULU icon
327
lululemon athletica
LULU
$13B
$383K 0.02%
4,879
-3,270
-40% -$218K
CY
328
DELISTED
Cypress Semiconductor
CY
$380K 0.02%
+24,956
New +$396K
CASY icon
329
Casey's General Stores
CASY
$31.9B
$378K 0.02%
+3,377
New +$386K
AVXS
330
DELISTED
AveXis, Inc. Common Stock
AVXS
$377K 0.02%
+3,409
New +$342K
VOYA icon
331
Voya Financial
VOYA
$8.94B
$376K 0.02%
+7,591
New +$326K
DFS
332
DELISTED
Discover Financial Services
DFS
$374K 0.02%
+4,859
New +$334K
CLH icon
333
Clean Harbors
CLH
$16.1B
$370K 0.02%
6,832
+2,003
+41% +$108K
ASH icon
334
Ashland
ASH
$3.04B
$355K 0.01%
+4,983
New +$344K
JUNO
335
DELISTED
Juno Therapeutics, Inc.
JUNO
$354K 0.01%
+7,754
New +$387K
SRPT icon
336
Sarepta Therapeutics
SRPT
$1.66B
$342K 0.01%
6,143
-21,670
-78% -$1.15M
CRS icon
337
Carpenter Technology
CRS
$30B
$337K 0.01%
+6,616
New +$328K
SXT icon
338
Sensient Technologies
SXT
$5.4B
$337K 0.01%
4,601
-9,735
-68% -$742K
ONCE
339
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$335K 0.01%
6,515
-9,901
-60% -$711K
BP icon
340
BP
BP
$113B
$325K 0.01%
+8,446
New +$306K
EQC
341
DELISTED
Equity Commonwealth
EQC
$320K 0.01%
+10,502
New +$318K
TRHC
342
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$320K 0.01%
+11,391
New +$334K
DVN icon
343
Devon Energy
DVN
$51.9B
$309K 0.01%
7,473
-155,225
-95% -$5.87M
MPWR icon
344
Monolithic Power Systems
MPWR
$65.5B
$308K 0.01%
+2,744
New +$319K
NAVI icon
345
Navient
NAVI
$774M
$305K 0.01%
+22,931
New +$290K
BIVV
346
DELISTED
Bioverativ Inc. Common Stock
BIVV
$305K 0.01%
5,664
TDS icon
347
Telephone and Data Systems
TDS
$3.91B
$300K 0.01%
+10,800
New +$296K
PNR icon
348
Pentair
PNR
$10.2B
$297K 0.01%
6,266
-68,826
-92% -$3.22M
SIRI icon
349
SiriusXM
SIRI
$10B
$291K 0.01%
5,427
FE icon
350
FirstEnergy
FE
$28.9B
$290K 0.01%
9,456
-73
-0.8% -$2.37K

Similar funds

Marshall Wace's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace held 541 positions worth $2.38B, up 11% from $2.15B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Marshall Wace deployed $112M of net new capital in Q4 2017, opening 208 new positions and adding to 87 existing holdings. Its largest new stake was Logitech: 2,215,424 shares worth $74.8M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $81.7M trimmed.

  • Marshall Wace's largest Q4 2017 buy was Logitech: 2,215,424 shares worth $74.8M.
  • Marshall Wace added most to Bank of America in Q4 2017, an estimated $43.7M increase.
  • Marshall Wace's biggest Q4 2017 reduction was Alphabet (Google) Class A, cutting an estimated $81.7M.
  • Marshall Wace fully exited iShares China Large-Cap ETF in Q4 2017, selling an estimated $39.6M.
  • Marshall Wace's ten largest holdings make up 28% of its $2.38B portfolio in Q4 2017.
  • Marshall Wace opened 208 new positions and closed 146 in Q4 2017.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $2.38B.

Based on Marshall Wace's 13F filing for Q4 2017, filed 14 Feb 2018.